Conference to sum up national Neonatal Care project implemented by UK BirthLink through VivaCell-MTS

13:20 • 09.06.11

11 neonatal departments in Yerevan and 7 departments in the regions received equipment worth of AMD 359 million in 2008, 2009 and 2010

VivaCell-MTS, a subsidiary of “Mobile TeleSystems” OJSC, is glad to announce that today the outcomes of the long-term national project on Neonatal Care implemented by VivaCell-MTS and BirthLink were summed up during a conference on Neonatal Care held in Yerevan, at Congress Hotel. The conference brought together doctors and nurses throughout Armenia, who were involved in the Neonatal Care project and upgraded their knowledge and skills

The conference was part of the long-term cooperation between VivaCell-MTS and UK-based BirthLink to improve the care of sick and vulnerable newborn babies in Armenia. It brought together doctors and nurses from Yerevan and regions of Armenia, who have participated and benefited from the project. Kathy Mellor, Director of BirthLink, and Dr. Hrant Kalenterian, Chief Neonatologist of Armenia, presented an overview of the project to date and looked at the achievements in the first two years. Nationally known specialists such as Pavel Mazmanyan and Arshak Djerdjerian also presented topics focused on different aspects of care of the sick newborn.

“As reports show, Armenia’s infant mortality rate is much higher than in countries like the US and UK. However, with good facilities and equipment, complemented by a program of continuous education and a sound medical knowledge, many of these deaths are preventable as proven by international experience. VivaCell-MTS realized that this is an issue where we couldn’t just watch and an immediate action is needed. Thus we extended hands to the initiative of BirthLink NGO. Today we are glad to see that there are tangible outcomes attained due to cooperation between VivaCell-MTS and BirthLink. We are happy that this massive social investment has proven to be justified. This is another long-term investment in the better future of our nation – we believe the major mission of the business is”, noted VivaCell-MTS General Manager Ralph Yirikian.

It’s too much early to speak about the overall long-term outcome of the project which is still under implementation. The first results are encouraging: thanks to the project the infant mortality rate has had nearly 15% reduction (based on the data available from Yerevan clinics included in the neonatal care project). At the same time the service providing capacity has increasing by 17% (based on the observation in the University Clinic N. 1 in Yerevan). Overall, more than 1000 infants have benefitted from this treatment as of today.

These are the preliminary results attained in frames of the project. Final monitoring and evaluation results will be presented to the medical community and the society.
The project worth of AMD 359 million commenced in 2008, and over the first three years embraced eleven neonatal departments in Yerevan and seven departments in five regions of Armenia.
• During this period the following equipment has been distributed to the clinics included in the project.
• 13 intensive care incubators
• 3 ventilators
• 20 non-invasive respiratory support systems
• More than 30 infusion pumps
• 20 oxygen monitors
• 22 heated warming mattresses

In addition, Nasal CPAP was introduced for the first time in Armenia. Also ultrasound scanning machine for brainscans on newborn babies introduced were – program is put in place for all neonatal departments in Yerevan. Equipment has been provided to support sick and low birth weight babies after delivery, with provision not to lose critical time and stabilize babies before transfer to Yerevan or regional centers. By improving facilities, transfer of some babies could be avoided. In addition to the equipment, education together with training and support will also be provided by experts from the UK, who voluntarily donated their time to share knowledge and expertise with Armenian colleagues.

In 2011 the third phase of the project will be implemented, this time concentrating on more neonatal centers in the regions, where newborn babies with complications can be transferred to from maternity hospitals, for ongoing care.